Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures
Status:
Unknown status
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness of pre-operative administration of
gabapentin 900 mg in management of acute post-operative pain in patients undergoing oral and
maxillofacial surgical procedures.